The role of lifestyle modifications, antioestrogens, cyclo-oxygenase-2 inhi
bitors and prophylactic mastectomy in reducing breast cancer is reviewed. I
f is concluded that avoiding postmenopausal obesity and regular physical ac
tivity are simple measures thar seem to reduce breast cancer risk. There is
no conclusive evidence that dietary modification and vitamin supplementati
on significantly reduce the risk of breast cancer. The evidence suggests th
at tamoxifen significantly reduces the risk of breast cancer in women at in
creased risk, but whether it reduces breast cancer mortality remains unknow
n. Ongoing clinical trials may prove that raloxifene is superior to tamoxif
en in breast cancer prevention due to its anti-oestrogenic effects on the e
ndometrium. Bilateral prophylactic mastectomy reduces the risk of breast ca
ncer by 90% in high risk women.